Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001235126-24-000036
Filing Date
2024-08-06
Accepted
2024-08-06 16:11:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 13D/A 13dalexx073124.txt SC 13D/A 4862
  Complete submission text file 0001235126-24-000036.txt   6351
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Subject) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: SC 13D/A | Act: 34 | File No.: 005-85256 | Film No.: 241179334
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5260 N PALM AVENUE SUITE 120 FRESNO CA 93704
Business Address
Boos Wayne W (Filed by) CIK: 0001987877 (see all company filings)

Type: SC 13D/A